Investment Stage

Focus Areas

About Investor

Owen Smith is a Partner at 4BIO Capital in London, focusing on seed and Series A investments of $100 K–$5 M into advanced-therapy ventures, including cell and gene therapies, RNA medicines and targeted therapeutics. He is based in London, England. Since joining 4BIO in 2018, he has supported the seeding and growth of early-stage biotech companies, drawing on his earlier life-science VC roles at Arthurian Life Sciences and Arix Bioscience and his scientific training.